I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 9.26 USD 2.77% Market Closed
Market Cap: 384.9m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of IMRX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IMRX Intrinsic Value
Not Available
I
Base Case Scenario
Compare IMRX to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IMRX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Immuneering Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Immuneering Corp

Current Assets 38.2m
Cash & Short-Term Investments 35.9m
Other Current Assets 2.3m
Non-Current Assets 12.5m
PP&E 4.6m
Intangibles 7m
Other Non-Current Assets 810.9k
Efficiency

Free Cash Flow Analysis
Immuneering Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Immuneering Corp

Revenue
0 USD
Operating Expenses
-64.3m USD
Operating Income
-64.3m USD
Other Expenses
2.6m USD
Net Income
-61.7m USD
Fundamental Scores

IMRX Profitability Score
Profitability Due Diligence

Immuneering Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Sustainable 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
25/100
Profitability
Score

Immuneering Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

IMRX Solvency Score
Solvency Due Diligence

Immuneering Corp's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Immuneering Corp's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMRX Price Targets Summary
Immuneering Corp

Wall Street analysts forecast IMRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMRX is 13.06 USD with a low forecast of 8.08 USD and a high forecast of 22.05 USD.

Lowest
Price Target
8.08 USD
13% Downside
Average
Price Target
13.06 USD
41% Upside
Highest
Price Target
22.05 USD
138% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Immuneering Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for IMRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IMRX Insider Trading
Buy and sell transactions by insiders